Royal Bank Of Canada Icad Inc Transaction History

Royal Bank Of Canada

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.27 - $2.06 $151 - $245	-119 Reduced 21.72%	429 $0
Q3 2023 Nov 14, 2023	SELL	$1.8 - $3.61 $1,053 - $2,111	-585 Reduced 51.63%	548 $1,000
Q2 2023 Aug 14, 2023	BUY	$1.14 - $1.63 $1,291 - $1,846	1,133 New	1,133 $1,000
Q3 2022 Nov 14, 2022	BUY	$2.22 - $4.32 $102 - $198	46 New	46 $0
Q2 2022 Aug 15, 2022	SELL	$3.02 - $4.56 $4,064 - $6,137	-1,346 Closed	0 $0

Q1 2022 May 16, 2022	SELL	$3.92 - $7.48 $16,656 - $31,782	-4,249 Reduced 75.94%	1,346 $6,000
Q4 2021 Feb 14, 2022	BUY	$6.7 - $11.38 $16,234 - $27,573	2,423 Added 76.39%	5,595 $41,000
Q3 2021 Nov 15, 2021	BUY	$10.11 - $17.56 $10,049 - $17,454	994 Added 45.64%	3,172 $34,000
Q2 2021 Aug 16, 2021	BUY	$14.9 - $20.82 $32,452 - $45,345	2,178 New	2,178 $38,000

6.29M

18.2K

37.5K

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $30.1M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.